Epinastine Eyelid Cream as a Practical Option for Patients With Glaucoma on Multidrug Topical Therapy: A Case Report
- PMID: 40786375
- PMCID: PMC12333317
- DOI: 10.7759/cureus.87589
Epinastine Eyelid Cream as a Practical Option for Patients With Glaucoma on Multidrug Topical Therapy: A Case Report
Abstract
Patients with glaucoma often require long-term use of multiple ophthalmic medications, which can make adherence to additional treatments, such as anti-allergic eye drops for seasonal allergic conjunctivitis, particularly challenging. Moreover, corticosteroid eye drops or ointments, commonly used to manage ocular allergy, are generally avoided in these patients due to the risk of increasing intraocular pressure. We report a case in which a patient with glaucoma, already undergoing multiple topical therapies, experienced recurrent allergic conjunctivitis and blepharitis each spring. The use of conventional anti-allergic eye drops had limited efficacy due to poor adherence associated with the complexity of the treatment regimen. To address this, a newly introduced epinastine cream was applied to the eyelids once daily as an alternative treatment. Following this change, the patient's allergic ocular symptoms improved substantially, with enhanced treatment compliance and no adverse effects on intraocular pressure during follow-up. This case suggests that non-ocular-drop formulations, such as eyelid creams, may offer a practical and effective approach for managing allergic eye disease in patients with glaucoma who are already on complex topical regimens.
Keywords: adherence; allergic conjunctivitis; epinastine; eye drops; eyelid cream; glaucoma.
Copyright © 2025, Nishijima et al.
Conflict of interest statement
Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures


Similar articles
-
Topical Innovation: A Report on Epinastine Eyelid Cream for Patients With Mild Atopic Keratoconjunctivitis.Cureus. 2025 Jun 26;17(6):e86792. doi: 10.7759/cureus.86792. eCollection 2025 Jun. Cureus. 2025. PMID: 40718327 Free PMC article.
-
Conjunctivitis in Adults with Atopic Dermatitis Treated with Dupilumab: An Observational Study of Clinical Characteristics, Symptomatology, and Treatment.Adv Ther. 2025 Jul;42(7):3285-3305. doi: 10.1007/s12325-025-03209-4. Epub 2025 May 19. Adv Ther. 2025. PMID: 40388089 Free PMC article.
-
Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery.Cochrane Database Syst Rev. 2017 Jul 3;7(7):CD010516. doi: 10.1002/14651858.CD010516.pub2. Cochrane Database Syst Rev. 2017. PMID: 28670710 Free PMC article.
-
Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis.Cochrane Database Syst Rev. 2022 Mar 3;3(3):CD013520. doi: 10.1002/14651858.CD013520.pub2. Cochrane Database Syst Rev. 2022. PMID: 35238405 Free PMC article.
-
Topical treatments for blepharokeratoconjunctivitis in children.Cochrane Database Syst Rev. 2017 Feb 7;2(2):CD011965. doi: 10.1002/14651858.CD011965.pub2. Cochrane Database Syst Rev. 2017. PMID: 28170093 Free PMC article.
References
-
- The burden of age-related macular degeneration: a value-based analysis. Brown MM, Brown GC, Sharma S, Stein JD, Roth Z, Campanella J, Beauchamp GR. Curr Opin Ophthalmol. 2006;17:257–266. - PubMed
Publication types
LinkOut - more resources
Full Text Sources